Eli Lilly & Co. vs. Nature's Sunshine Products Inc.
Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| LLY | NATR | |
|---|---|---|
| Market Cap | $1.09 trillion | $272.91 million |
| Revenue (TTM) | $79.67 billion | $492.02 million |
| Net Income (TTM) | $26.71 billion | $18.70 million |
LLY leads on 3 of 3 size & scale factors.
Valuation
| LLY | NATR | |
|---|---|---|
| P/E Ratio | 39.62 | 14.97 |
| Price / Book | 32.11 | 1.61 |
| Price / Sales | 13.65 | 0.55 |
NATR leads on 3 of 3 valuation factors.
Profitability
| LLY | NATR | |
|---|---|---|
| Net Margin | 33.53% | 3.80% |
| Return on Equity | 78.84% | 11.05% |
LLY leads on 2 of 2 profitability factors.
Dividend
| LLY | NATR | |
|---|---|---|
| Dividend Yield | 0.59% | — |
| Payout Ratio | 23.23 | — |
LLY and NATR split the dividend factors evenly.
Risk & Sentiment
| LLY | NATR | |
|---|---|---|
| Short Interest | 1.29% | 1.46% |
LLY leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, NATR overview, NATR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.